Biosimilars Market Opportunities, Business Forecast To 2030
The report "Biosimilars Market by Drug Class (Monoclonal Antibodies, Recombinant Hormones, Recombinant Growth Factors, Immunomodulators, Anti-Inflammatory Agents, and Others), by Application (Oncology, Blood Disorders, Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies))- Global Forecasts to 2030" The global Biosimilars Market is projected to reach USD 14.9 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 24.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the Increase in non-invasive cancer treatments through radiation therapy. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17319 Competitive Dashboard: The prominent key players operating in the global Biosimilars Market are Amgen Inc. (U.S.) Biocon Ltd. (India) Celltrion, Inc. (South Korea) Dr...